Theriva Biologics Inc (TOVX)
1.28
+0.02
(+1.59%)
USD |
NYAM |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Max Drawdown (5Y): 99.81% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.81% |
| September 30, 2024 | 99.81% |
| August 31, 2024 | 99.81% |
| July 31, 2024 | 99.81% |
| June 30, 2024 | 99.81% |
| May 31, 2024 | 99.81% |
| April 30, 2024 | 99.81% |
| March 31, 2024 | 99.81% |
| February 29, 2024 | 99.81% |
| January 31, 2024 | 99.81% |
| December 31, 2023 | 99.81% |
| November 30, 2023 | 99.81% |
| October 31, 2023 | 99.81% |
| September 30, 2023 | 99.81% |
| August 31, 2023 | 99.81% |
| July 31, 2023 | 99.81% |
| June 30, 2023 | 99.81% |
| May 31, 2023 | 99.81% |
| April 30, 2023 | 99.81% |
| March 31, 2023 | 99.81% |
| February 28, 2023 | 99.81% |
| January 31, 2023 | 99.81% |
| December 31, 2022 | 99.81% |
| November 30, 2022 | 99.81% |
| October 31, 2022 | 99.81% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.81% |
| August 31, 2022 | 99.81% |
| July 31, 2022 | 99.81% |
| June 30, 2022 | 99.81% |
| May 31, 2022 | 99.81% |
| April 30, 2022 | 99.81% |
| March 31, 2022 | 99.81% |
| February 28, 2022 | 99.81% |
| January 31, 2022 | 99.81% |
| December 31, 2021 | 99.81% |
| November 30, 2021 | 99.81% |
| October 31, 2021 | 99.81% |
| September 30, 2021 | 99.81% |
| August 31, 2021 | 99.81% |
| July 31, 2021 | 99.81% |
| June 30, 2021 | 99.81% |
| May 31, 2021 | 99.81% |
| April 30, 2021 | 99.81% |
| March 31, 2021 | 99.81% |
| February 28, 2021 | 99.81% |
| January 31, 2021 | 99.81% |
| December 31, 2020 | 99.81% |
| November 30, 2020 | 99.81% |
| October 31, 2020 | 99.81% |
| September 30, 2020 | 99.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.72%
Minimum
Nov 2019
99.81%
Maximum
Mar 2020
99.80%
Average
99.81%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Merck & Co Inc | 27.26% |
| Pro-Dex Inc | 69.11% |
| BioCardia Inc | 98.91% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -76.94 |
| Beta (5Y) | 1.337 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 103.7% |
| Historical Sharpe Ratio (5Y) | -0.5753 |
| Historical Sortino (5Y) | -1.273 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.50% |